Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Pooled Analysis of Cardiovascular Events from Clinical Trials Evaluating Acalabrutinib Monotherapy in Patients with Chronic Lymphocytic Leukemia (CLL)

Jennifer R Brown, MD PhD, John C. Byrd, MD, Paolo Ghia, MD PhD, Jeff P Sharman, MD, Peter Hillmen, MBChB, PhD FRCP, FRCPath, Deborah M. Stephens, DO, Clare Sun, MD, Wojciech Jurczak, John M. Pagel, MDPhD, Alessandra Ferrajoli, MD, Priti Patel, MD, Marshall Baek, Tamara Lezhava, Nataliya Kuptsova-Clarkson, MD, Javid J. Moslehi, MD, Richard R. Furman, MD

Blood (2020) 136 (Supplement 1): 52–54.

https://doi.org/10.1182/blood-2020-134797

Published: 2020

Journal Articles

Phase 1 Trial of Human IL-15 (rhIL-15) and Obinutuzumab for Relapsed and Refractory Chronic Lymphocytic Leukemia

Milos D. Miljkovic, MDMSc, Kevin C Conlon, MD, Jennifer Hsu, RN, Clare Sun, MD, Adrian Wiestner, MD PhD, Thomas A. Waldmann, MD

Blood (2019) 134 (Supplement_1): 3052.

https://doi.org/10.1182/blood-2019-130807

Published: 2019

Journal Articles

Response to the Shingrix Varicella Zoster Virus (VZV) Vaccine in Patients with Chronic Lymphocytic Leukemia (CLL) That Are Treatment Naive or Treated with a Bruton's Tyrosine Kinase Inhibitor (BTK-I)

Christopher Pleyer, MD, Jeffrey Cohen, MD, Susan Soto, Mir Ali, PhD, Inhye E Ahn, MD, Pia Nierman, BSN, MA, RN, Janet Valdez, Jennifer Lotter, PA-C, Jeanine Superata, RN, Xin Tian, Adrian Wiestner, MD PhD, Clare Sun, MD

Blood (2019) 134 (Supplement_1): 3053.

https://doi.org/10.1182/blood-2019-121675

Published: 2019

Journal Articles

Spatial Genomic Heterogeneity in Chronic Lymphocytic Leukemia

Clare Sun, MD, Yun-Ching Chen, PhD, Aina Zurita Martinez, Delong Liu, PhD, Daniel Rosebrock, Gad Getz, PhD, Mehdi Pirooznia, MD PhD, Catherine J. Wu, MD, Adrian Wiestner, MD PhD

Blood (2019) 134 (Supplement_1): 3017.

https://doi.org/10.1182/blood-2019-123441

Published: 2019

Journal Articles

Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib Show Expansion of T-Cell Clonotypes Composed of Antitumor Cytotoxic CD8+ T-Cells

Maria Joao Baptista, PhD PharmD, Sivasubramanian Baskar, Keyvan Keyvanfar, Erika M Gaglione, Inhye E Ahn, MD, Adrian Wiestner, MD PhD, Clare Sun, MD

Blood (2019) 134 (Supplement_1): 3030.

https://doi.org/10.1182/blood-2019-127131

Published: 2019

Journal Articles

A CD19/CD3 Bispecific Antibody Induces Superior T Cell Responses Against Chronic Lymphocytic Leukemia When Combined with Ibrutinib

Maissa Mhibik, PhD, Erika M Gaglione, Amy Blackburn, Keyvan Keyvanfar, Clare Sun, MD, Inhye E Ahn, MD, Maria Joao Baptista, Junpeng Qi, PhD, Christoph Rader, PhD, Adrian Wiestner, MD PhD

Blood (2019) 134 (Supplement_1): 2861.

https://doi.org/10.1182/blood-2019-126186

Published: 2019

Journal Articles

Diverging Clonal Evolution during Sequential Therapy with Chemoimmunotherapy Followed By BTK Inhibitors

Inhye E Ahn, MD, Yun-Ching Chen, PhD, Chingiz Underbayev, MD PhD, Erika M Gaglione, Clare Sun, MD, Susan Soto, Pia Nierman, Mehdi Pirooznia, MD PhD, Adrian Wiestner, MD PhD

Blood (2019) 134 (Supplement_1): 850.

https://doi.org/10.1182/blood-2019-122142

Published: 2019

Journal Articles

Serum B-Cell Maturation Antigen As a Biomarker for Chronic Lymphocytic Leukemia Treated with Ibrutinib

Clare Sun, MD, Camilia Soof, BS, Alankrita Taneja, MD, Sarah E. M. Herman, PhD, Erika Cook, BA, Kyle Udd, BA, Haiming Chen, MD PhD, Eric Sanchez, BA, Xin Tian, PhD, Inhye E. Ahn, MD, James R Berenson, MD, Adrian Wiestner, MD

Blood (2017) 130 (Supplement 1): 4031.

https://doi.org/10.1182/blood.V130.Suppl_1.4031.4031

Published: 2017

Journal Articles

High Prevalence of Multiple B Cell Clones in Patients with Chronic Lymphocytic Leukemia

Alankrita Taneja, MBBS, Clare Sun, MD, Constance Yuan, Maryalice Stetler-Stevenson, Susan Soto, Gerald Marti, Adrian Wiestner, MD

Blood (2017) 130 (Supplement 1): 1712.

https://doi.org/10.1182/blood.V130.Suppl_1.1712.1712

Published: 2017

Journal Articles

Transcriptome Analysis of the Lymph Node Microenvironment in Chronic Lymphocytic Leukemia

Clare Sun, MD, Delong Liu, PhD, Nakhle S. Saba, MD, Sarah E. M. Herman, PhD, Mehdi Pirooznia, MD PhD, Adrian Wiestner, MD

Blood (2017) 130 (Supplement 1): 1718.

https://doi.org/10.1182/blood.V130.Suppl_1.1718.1718

Published: 2017

Journal Articles

The Landscape of Dynamic Genetic Changes in Ibrutinib-Treated CLL

Dan A. Landau, MD PhD, Clare Sun, MD, Daniel Rosebrock, Mariela Campbell, Sarah E. M. Herman, PhD, Julia Hoellenriegel, MS, Mohammed Farooqui, Wandi Zhang, MD, Donna S. Neuberg, ScD, Dimitri Livitz, Ignaty Leshchiner, Gad Getz, PhD, Jan Burger, MD PhD, Adrian Wiestner, MD PhD, Catherine J Wu, MD

Blood (2016) 128 (22): 188.

https://doi.org/10.1182/blood.V128.22.188.188

Published: 2016

Journal Articles

Dynamic Alterations in Gene Expression in Ibrutinib Treated CLL Reveal Profound Impact on Multiple Signaling Pathways

Sarah E. M. Herman, PhD, Delong Liu, PhD, Dan A. Landau, MD PhD, Clare Sun, MD, Mohammed Farooqui, Catherine J Wu, MD, Adrian Wiestner, MDPhD

Blood (2016) 128 (22): 189.

https://doi.org/10.1182/blood.V128.22.189.189

Published: 2016

Journal Articles

Lymphocyte Activation Gene 3-a Novel Therapeutic Target in Chronic Lymphocytic Leukemia

Mika Shapiro, PhD, Ben-Zion Katz, PhD, Chava Perry, MD PhD, Clare Sun, MD, Nili Dezorella, M.Sc, Sigi Kay, PhD, Irit Avivi, MD, Adrian Wiestner, MD PhD, Herishanu Yair, MD

Blood (2016) 128 (22): 2018.

https://doi.org/10.1182/blood.V128.22.2018.2018

Published: 2016

Journal Articles

Ibrutinib Inhibits Both B-Cell Receptor and Toll-like Receptor Signaling in Chronic Lymphocytic Leukemia

Sarah E. M. Herman, PhD, Erin M. McAuley, BS, Deanna H. Wong, BS, Clare Sun, MD, Delong Liu, PhD, Adrian Wiestner, MD PhD

Blood (2015) 126 (23): 313.

https://doi.org/10.1182/blood.V126.23.313.313

Published: 2015

Journal Articles

Ibrutinib Responsive Micro-RNAs and Upregulation of Tumor Suppressor Targets in Chronic Lymphocytic Leukemia

Layla M Saleh, MD, Weixin Wang, PhD, Sarah E. M. Herman, PhD, Mohammed Farooqui, DO, Clare Sun, MD, Emily Barber, B.S., Meghan Corrigan-Cummins, B.S., Nakhle Saba, MD, Hasan Awad, MD, PhD, Adrian Wiestner, MD PhD, Katherine R. Calvo, MD, PhD

Blood (2015) 126 (23): 487.

https://doi.org/10.1182/blood.V126.23.487.487

Published: 2015

Journal Articles

FLT3 Signaling Enhances Stemness in Murine MLL-AF9 Acute Myeloid Leukemia.

Clare Sun, MD, Christopher S. Seet, MD, Jun Zhang, PhD, Yechen Xiao, PhD, Dewen You, PhD, Jiwang Zhang, MD, PhD

Blood (2012) 120 (21): 2980.

https://doi.org/10.1182/blood.V120.21.2980.2980

Published: 2012

Journal Articles

Focal Adhesion Kinase Inactivation Reduces the Development of Acute Leukemia and Partially Rescues Hematopoietic Stem Cell Defects in Pten -Knockout Mice

Dewen You, PhD, Andrew Volk, Clare Sun, MD, Junping Xin, MD, PhD, Geunhyoung Ha, PhD, Chunliu Pan, PhD, Rachel Schmidt, Patience Oladeinde, Wei Wei, Subing Zhang, MD, Eun-Kyoung Breuer, PhD, Peter Breslin, PhD, Jiwang Zhang, MD, PhD

Blood (2012) 120 (21): 864.

https://doi.org/10.1182/blood.V120.21.864.864

Published: 2012

NARROW

Pooled Analysis of Cardiovascular Events from Clinical Trials Evaluating Acalabrutinib Monotherapy in Patients with Chronic Lymphocytic Leukemia (CLL)

Phase 1 Trial of Human IL-15 (rhIL-15) and Obinutuzumab for Relapsed and Refractory Chronic Lymphocytic Leukemia

Response to the Shingrix Varicella Zoster Virus (VZV) Vaccine in Patients with Chronic Lymphocytic Leukemia (CLL) That Are Treatment Naive or Treated with a Bruton's Tyrosine Kinase Inhibitor (BTK-I)

Spatial Genomic Heterogeneity in Chronic Lymphocytic Leukemia

Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib Show Expansion of T-Cell Clonotypes Composed of Antitumor Cytotoxic CD8+ T-Cells

A CD19/CD3 Bispecific Antibody Induces Superior T Cell Responses Against Chronic Lymphocytic Leukemia When Combined with Ibrutinib

Diverging Clonal Evolution during Sequential Therapy with Chemoimmunotherapy Followed By BTK Inhibitors

Serum B-Cell Maturation Antigen As a Biomarker for Chronic Lymphocytic Leukemia Treated with Ibrutinib

High Prevalence of Multiple B Cell Clones in Patients with Chronic Lymphocytic Leukemia

Transcriptome Analysis of the Lymph Node Microenvironment in Chronic Lymphocytic Leukemia

The Landscape of Dynamic Genetic Changes in Ibrutinib-Treated CLL

Dynamic Alterations in Gene Expression in Ibrutinib Treated CLL Reveal Profound Impact on Multiple Signaling Pathways

Lymphocyte Activation Gene 3-a Novel Therapeutic Target in Chronic Lymphocytic Leukemia

Ibrutinib Inhibits Both B-Cell Receptor and Toll-like Receptor Signaling in Chronic Lymphocytic Leukemia

Ibrutinib Responsive Micro-RNAs and Upregulation of Tumor Suppressor Targets in Chronic Lymphocytic Leukemia

FLT3 Signaling Enhances Stemness in Murine MLL-AF9 Acute Myeloid Leukemia.

Focal Adhesion Kinase Inactivation Reduces the Development of Acute Leukemia and Partially Rescues Hematopoietic Stem Cell Defects in Pten -Knockout Mice

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only